Market Cap 259.61M
Revenue (ttm) 0.00
Net Income (ttm) 3.75M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,624,891
Avg Vol 1,913,436
Day's Range N/A - N/A
Shares Out 1.38B
Stochastic %K 8%
Beta 1.18
Analysts Strong Buy
Price Target $4.00

Company Profile

CytoDyn Inc., a clinical-stage biotechnology company, develops treatments for multiple therapeutic indications. It is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19. The company's leronlimab is currently under phase 2 development for the treatment of micro-satellite stable colorectal cancer, and solid tumors in oncology, such as metastatic triple-negative breast cancer. It has...

Industry: Biotechnology
Sector: Healthcare
Phone: 360 980 8524
Fax: 360 799 5954
Address:
1111 Main Street, Suite 660, Vancouver, United States
Twinter11
Twinter11 Aug. 5 at 10:42 PM
$CYDY part 3 "Key aspects of how this study illuminates neuroimmune pathology include: Recreating the Human Microenvironment in 3D: Traditional animal models often fail to accurately capture human neuroinflammation. By building a modular forebrain organoid that integrates both iPSC-derived microglia (innate immunity) and CD8+ T cells (adaptive immunity), the researchers could watch multicellular pathology unfold in real time. -Proving the Microglia-T Cell Bridge: When the organoids were exposed to Alzheimer's-related pathology (like amyloid-beta), the resident microglia became activated and started pumping out specific chemokine signals—namely CCL4 and CCL5 (acting via CCR1 and CCR5), alongside CXCL10 (acting via CXCR3). Crucially, the study showed that without microglia present, the T cells failed to migrate inward. Microglia act as the literal gatekeepers and signal-callers pulling adaptive immune cells into brain tissue". (cont)..
1 · Reply
Twinter11
Twinter11 Aug. 5 at 10:35 PM
$CYDY alz part 2 AI "The connection between CCR5 signaling, T-cell infiltration, and autophagy involves several key dynamics: The Breakdown of Cellular Housekeeping: When chronic neuroinflammation takes over—driven by activated microglia pulling in CD8+ T cells via the CCL4/CCL5-CCR5 axis—neurons and glial cells experience severe metabolic stress. This inflammatory onslaught overwhelms and disrupts normal autophagic pathways, preventing cells from clearing out toxic waste and accelerating degeneration. Rescuing the Cleanup Machinery: The Tsinghua University organoid study demonstrated that pharmacologically targeting CCR5 (or CXCR3) did more than just block the physical traffic of invading T cells. It also successfully modulated and restored autophagy in a microglia-dependent manner".
0 · Reply
Hello5
Hello5 Aug. 5 at 10:34 PM
$CYDY the shorts are on the same side as Fauci - lying and screwed !!
0 · Reply
HouseintheCountry
HouseintheCountry Aug. 5 at 10:03 PM
$CYDY drip, drip, drip, annoying ain’t it..
0 · Reply
Twinter11
Twinter11 Aug. 5 at 8:32 PM
$CYDY An integrated human forebrain organoid reveals microglia-mediated CD8+ T cell recruitment and neuroimmune dysfunction in Alzheimer’s disease pathology An integrated human forebrain organoid reveals microglia-mediated CD8+ T cell recruitment and neuroimmune dysfunction in Alzheimer’s disease pathology https://share.google/ex9xT4Qv60Aj7hwvO "We identified the CCL5-CCR5 axis as the master integrator of this neuroimmune transition. Microglia-derived CCL5 directly drives CD8+ T cell chemotaxis, while cell-cell interaction analyses revealed extensive CCR5-associated signaling with neurons and progenitors (Fig. 3H-J). Inhibiting CCR5 successfully blocked T cell recruitment (Fig. 4H) but also impacted cell-specific autophagy, indicating that CCR5 acts as a pleiotropic regulator of neuroimmune function rather than a simple chemoattractant. Repurposing clinical CCR5 antagonists
1 · Reply
WheelsAreRolling
WheelsAreRolling Aug. 5 at 8:25 PM
$CYDY Like Dr. J said, when we are done compiling all of our data there won’t be any questions. It will be complete.
0 · Reply
u2rocksme
u2rocksme Aug. 5 at 8:17 PM
$CYDY BULLISH!!! STAY THE COURSE!!! INCREDIBLE DATA IS THE TRUTH!!! SAFE AND EXTREMELY EFFECTIVE MIGHTY MIRACLE DRUG AND MOLECULE LERONLIMAB FIGHTS CANCER AND SAVES LIVES!!! MUCH MORE TO COME!!! https://www.asco.org/abstracts-presentations/262713
2 · Reply
GhostofCytomight
GhostofCytomight Aug. 5 at 8:04 PM
$CYDY THEY wanna kill our spirit, but guess what? They’re only igniting us.‼️🔥 WE WONT BACK DOWN‼️
0 · Reply
VandalGrimshot1700
VandalGrimshot1700 Aug. 5 at 7:58 PM
$CYDY uneventful and uninspiring. Just waiting on news.
0 · Reply
my69z
my69z Aug. 5 at 7:37 PM
$CYDY 1st confirmed reversal of scarring, from any source. Now looking to confirm LL & ICI dosing via blood stream, of any tumor type / stage / location. Wow !! ...
1 · Reply
Latest News on CYDY
No data available.
Twinter11
Twinter11 Aug. 5 at 10:42 PM
$CYDY part 3 "Key aspects of how this study illuminates neuroimmune pathology include: Recreating the Human Microenvironment in 3D: Traditional animal models often fail to accurately capture human neuroinflammation. By building a modular forebrain organoid that integrates both iPSC-derived microglia (innate immunity) and CD8+ T cells (adaptive immunity), the researchers could watch multicellular pathology unfold in real time. -Proving the Microglia-T Cell Bridge: When the organoids were exposed to Alzheimer's-related pathology (like amyloid-beta), the resident microglia became activated and started pumping out specific chemokine signals—namely CCL4 and CCL5 (acting via CCR1 and CCR5), alongside CXCL10 (acting via CXCR3). Crucially, the study showed that without microglia present, the T cells failed to migrate inward. Microglia act as the literal gatekeepers and signal-callers pulling adaptive immune cells into brain tissue". (cont)..
1 · Reply
Twinter11
Twinter11 Aug. 5 at 10:35 PM
$CYDY alz part 2 AI "The connection between CCR5 signaling, T-cell infiltration, and autophagy involves several key dynamics: The Breakdown of Cellular Housekeeping: When chronic neuroinflammation takes over—driven by activated microglia pulling in CD8+ T cells via the CCL4/CCL5-CCR5 axis—neurons and glial cells experience severe metabolic stress. This inflammatory onslaught overwhelms and disrupts normal autophagic pathways, preventing cells from clearing out toxic waste and accelerating degeneration. Rescuing the Cleanup Machinery: The Tsinghua University organoid study demonstrated that pharmacologically targeting CCR5 (or CXCR3) did more than just block the physical traffic of invading T cells. It also successfully modulated and restored autophagy in a microglia-dependent manner".
0 · Reply
Hello5
Hello5 Aug. 5 at 10:34 PM
$CYDY the shorts are on the same side as Fauci - lying and screwed !!
0 · Reply
HouseintheCountry
HouseintheCountry Aug. 5 at 10:03 PM
$CYDY drip, drip, drip, annoying ain’t it..
0 · Reply
Twinter11
Twinter11 Aug. 5 at 8:32 PM
$CYDY An integrated human forebrain organoid reveals microglia-mediated CD8+ T cell recruitment and neuroimmune dysfunction in Alzheimer’s disease pathology An integrated human forebrain organoid reveals microglia-mediated CD8+ T cell recruitment and neuroimmune dysfunction in Alzheimer’s disease pathology https://share.google/ex9xT4Qv60Aj7hwvO "We identified the CCL5-CCR5 axis as the master integrator of this neuroimmune transition. Microglia-derived CCL5 directly drives CD8+ T cell chemotaxis, while cell-cell interaction analyses revealed extensive CCR5-associated signaling with neurons and progenitors (Fig. 3H-J). Inhibiting CCR5 successfully blocked T cell recruitment (Fig. 4H) but also impacted cell-specific autophagy, indicating that CCR5 acts as a pleiotropic regulator of neuroimmune function rather than a simple chemoattractant. Repurposing clinical CCR5 antagonists
1 · Reply
WheelsAreRolling
WheelsAreRolling Aug. 5 at 8:25 PM
$CYDY Like Dr. J said, when we are done compiling all of our data there won’t be any questions. It will be complete.
0 · Reply
u2rocksme
u2rocksme Aug. 5 at 8:17 PM
$CYDY BULLISH!!! STAY THE COURSE!!! INCREDIBLE DATA IS THE TRUTH!!! SAFE AND EXTREMELY EFFECTIVE MIGHTY MIRACLE DRUG AND MOLECULE LERONLIMAB FIGHTS CANCER AND SAVES LIVES!!! MUCH MORE TO COME!!! https://www.asco.org/abstracts-presentations/262713
2 · Reply
GhostofCytomight
GhostofCytomight Aug. 5 at 8:04 PM
$CYDY THEY wanna kill our spirit, but guess what? They’re only igniting us.‼️🔥 WE WONT BACK DOWN‼️
0 · Reply
VandalGrimshot1700
VandalGrimshot1700 Aug. 5 at 7:58 PM
$CYDY uneventful and uninspiring. Just waiting on news.
0 · Reply
my69z
my69z Aug. 5 at 7:37 PM
$CYDY 1st confirmed reversal of scarring, from any source. Now looking to confirm LL & ICI dosing via blood stream, of any tumor type / stage / location. Wow !! ...
1 · Reply
Wenwen_Chang
Wenwen_Chang Aug. 5 at 7:18 PM
$CYDY I am buying weekly. I might stop when it hits $25. Before then, I am trying to accumulate as many shares as I can.
1 · Reply
WagonTrain
WagonTrain Aug. 5 at 6:06 PM
$CYDY Gonna head for the sweet spot -
0 · Reply
Buyout_offer
Buyout_offer Aug. 5 at 5:44 PM
$CYDY Only down 95% and Still Waiting?!! According to fellow longs and CYDY testing results everything is rainbows and unicorns. Yet we continue to go lower with money bleeding out. Is Long CYDY a death sentence? Will we see a turn around in our lifetime or do we need to ride this untill we go bankrupt or down another 90%. I thought averaging down would be the answer, but not so sure.
4 · Reply
GhostofCytomight
GhostofCytomight Aug. 5 at 5:10 PM
$CYDY THEY KEEP FLOODING THE BID TO KEEP IT DOWN‼️😂 GOD WELLING VOLUME GETS YOU‼️
0 · Reply
GhostofCytomight
GhostofCytomight Aug. 5 at 5:03 PM
$CYDY LONGS HAVE ADDED THE FOLLOWING TO THEIR VOCAB‼️😆 PDL1 ctDNA CHECKPOINT INHIBITORS Upregulation Functional cure Macrophage Immune dysfunction Immune exhaustion Tumor microenvironment Tregs Cold and Hot tumors
1 · Reply
my69z
my69z Aug. 5 at 4:38 PM
$CYDY I remember years ago, a worlds largest fund manager said she was laughed @ for buying 30m shares @ $30 share price, of Apple ...
0 · Reply
GhostofCytomight
GhostofCytomight Aug. 5 at 3:35 PM
$CYDY WHAT ARE YOU UP TO MAX? Whats your role in this story?Hmmmm
0 · Reply
GhostofCytomight
GhostofCytomight Aug. 5 at 3:30 PM
$CYDY MAX INTERESTING ‼️LERON LERONLIMAB?
0 · Reply
WheelsAreRolling
WheelsAreRolling Aug. 5 at 3:30 PM
$CYDY I love this price range 😎
0 · Reply
Candyman1801
Candyman1801 Aug. 5 at 3:16 PM
$CYDY Well, today makes 15 losing weeks of being in the RED. Just another losing week. Waiting for the speculators to comment on this fact....and please stop with the Bullish shit. The only Bullish shit is you with your bullshit.
1 · Reply
my69z
my69z Aug. 5 at 3:16 PM
$CYDY Validating for any type, stage & location, of cancers..... Leronlimab allows ICI to also dose via the blood stream... Is the holy grail of what Dr. J is doing, & @ every step .... "Unassalable, rock solid, data" .... Godspeed Dr. J & team. ...
0 · Reply
my69z
my69z Aug. 5 at 2:55 PM
$CYDY Potentially addressing Glioblastoma from dosing via the blood stream As Stand-alone & Prime-n-Pair..... Validates every status of cancers, for LL. Speechless @ the paradim shift results. ...
0 · Reply